skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 781,987  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Aged, 80 And Over remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Breast cancer development in transsexual subjects receiving cross-sex hormone treatment
Material Type:
Article
Add to My Research

Breast cancer development in transsexual subjects receiving cross-sex hormone treatment

Journal of sexual medicine, 2013-12, Vol.10 (12), p.3129 [Peer Reviewed Journal]

2013 International Society for Sexual Medicine. ;EISSN: 1743-6109 ;DOI: 10.1111/jsm.12319 ;PMID: 24010586

Digital Resources/Online E-Resources

2
Relationships between the age of 25,445 men attending infertility clinics and sperm chromatin structure assay (SCSA®) defined sperm DNA and chromatin integrity
Material Type:
Article
Add to My Research

Relationships between the age of 25,445 men attending infertility clinics and sperm chromatin structure assay (SCSA®) defined sperm DNA and chromatin integrity

Fertility and sterility, 2020-08, Vol.114 (2), p.311-320 [Peer Reviewed Journal]

2020 American Society for Reproductive Medicine ;Copyright © 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. ;ISSN: 0015-0282 ;EISSN: 1556-5653 ;DOI: 10.1016/j.fertnstert.2020.03.028 ;PMID: 32653083

Full text available

3
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
Material Type:
Article
Add to My Research

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results

Breast cancer research and treatment, 2017-02, Vol.161 (3), p.575-586 [Peer Reviewed Journal]

The Author(s) 2016 ;COPYRIGHT 2017 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, 2017. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-016-4085-4 ;PMID: 28008555 ;CODEN: BCTRD6

Full text available

4
Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
Material Type:
Article
Add to My Research

Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients

Breast cancer research and treatment, 2013-01, Vol.137 (2), p.465-470 [Peer Reviewed Journal]

Springer Science+Business Media New York 2012 ;2014 INIST-CNRS ;COPYRIGHT 2013 Springer ;Springer Science+Business Media New York 2013 ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-012-2355-3 ;PMID: 23224235 ;CODEN: BCTRD6

Full text available

5
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort
Material Type:
Article
Add to My Research

Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort

British journal of cancer, 2019-12, Vol.121 (12), p.991-1000 [Peer Reviewed Journal]

Copyright Nature Publishing Group Dec 2019 ;The Author(s), under exclusive licence to Cancer Research UK 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0619-y ;PMID: 31719684

Full text available

6
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Material Type:
Article
Add to My Research

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

Cancer cell, 2018-09, Vol.34 (3), p.427-438.e6 [Peer Reviewed Journal]

2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;ISSN: 1535-6108 ;EISSN: 1878-3686 ;DOI: 10.1016/j.ccell.2018.08.008 ;PMID: 30205045

Full text available

7
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group
Material Type:
Article
Add to My Research

E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group

Journal of clinical oncology, 2021-10, Vol.39 (28), p.3171-3181 [Peer Reviewed Journal]

2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.00944 ;PMID: 34357781

Full text available

8
Relationship between semen production and medical comorbidity
Material Type:
Article
Add to My Research

Relationship between semen production and medical comorbidity

Fertility and sterility, 2015-01, Vol.103 (1), p.66-71 [Peer Reviewed Journal]

American Society for Reproductive Medicine ;2015 American Society for Reproductive Medicine ;Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. ;ISSN: 0015-0282 ;EISSN: 1556-5653 ;DOI: 10.1016/j.fertnstert.2014.10.017 ;PMID: 25497466

Full text available

9
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer
Material Type:
Article
Add to My Research

Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2141-2148 [Peer Reviewed Journal]

2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2016.70.8297 ;PMID: 28291390

Full text available

10
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial
Material Type:
Article
Add to My Research

Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial

The lancet oncology, 2017-06, Vol.18 (6), p.743-754 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 1, 2017 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30313-3 ;PMID: 28526538

Full text available

11
Genomic Characterization of de novo Metastatic Breast Cancer
Material Type:
Article
Add to My Research

Genomic Characterization of de novo Metastatic Breast Cancer

Clinical cancer research, 2021-02, Vol.27 (4), p.1105-1118 [Peer Reviewed Journal]

2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-1720 ;PMID: 33293374

Full text available

12
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
Material Type:
Article
Add to My Research

Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial

The lancet oncology, 2017-06, Vol.18 (6), p.732-742 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 1, 2017 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30312-1 ;PMID: 28526536

Full text available

13
Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
Material Type:
Article
Add to My Research

Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

Annals of surgical oncology, 2018-09, Vol.25 (9), p.2596-2602 [Peer Reviewed Journal]

Society of Surgical Oncology 2018 ;Annals of Surgical Oncology is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-018-6637-9 ;PMID: 29978369

Full text available

14
Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series
Material Type:
Article
Add to My Research

Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series

The oncologist (Dayton, Ohio), 2015-06, Vol.20 (6), p.586-592 [Peer Reviewed Journal]

2015 AlphaMed Press ;AlphaMed Press. ;AlphaMed Press 2015 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2014-0243 ;PMID: 25948676

Full text available

15
Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs
Material Type:
Article
Add to My Research

Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs

Clinical cancer research, 2020-03, Vol.26 (5), p.1105-1113 [Peer Reviewed Journal]

2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-19-2350 ;PMID: 31772121

Full text available

16
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer
Material Type:
Article
Add to My Research

Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer

Breast cancer (Tokyo, Japan), 2024-03, Vol.31 (3), p.485-495 [Peer Reviewed Journal]

The Author(s) 2024 ;2024. The Author(s). ;ISSN: 1340-6868 ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-024-01560-y ;PMID: 38507145

Digital Resources/Online E-Resources

17
Oxidative Stress-Cause or consequence of male genital tract disorders?
Material Type:
Article
Add to My Research

Oxidative Stress-Cause or consequence of male genital tract disorders?

The Prostate, 2012-06, Vol.72 (9), p.977-983 [Peer Reviewed Journal]

Copyright © 2011 Wiley Periodicals, Inc. ;2015 INIST-CNRS ;ISSN: 0270-4137 ;EISSN: 1097-0045 ;DOI: 10.1002/pros.21502 ;PMID: 22025397 ;CODEN: PRSTDS

Full text available

18
Prognostic factors in male breast cancer: a population-based study
Material Type:
Article
Add to My Research

Prognostic factors in male breast cancer: a population-based study

Breast cancer research and treatment, 2016-04, Vol.156 (3), p.539-548 [Peer Reviewed Journal]

Springer Science+Business Media New York 2016 ;COPYRIGHT 2016 Springer ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-016-3768-1 ;PMID: 27039306 ;CODEN: BCTRD6

Full text available

19
Adjuvant systemic therapy for male breast carcinoma
Material Type:
Article
Add to My Research

Adjuvant systemic therapy for male breast carcinoma

Cancer, 2005-12, Vol.104 (11), p.2359-2364 [Peer Reviewed Journal]

Copyright © 2005 American Cancer Society ;2006 INIST-CNRS ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.21526 ;PMID: 16270318 ;CODEN: CANCAR

Digital Resources/Online E-Resources

20
The prognostic significance of tumour―stroma ratio in oestrogen receptor-positive breast cancer
Material Type:
Article
Add to My Research

The prognostic significance of tumour―stroma ratio in oestrogen receptor-positive breast cancer

British journal of cancer, 2014-04, Vol.110 (7), p.1744-1747 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright Nature Publishing Group Apr 1, 2014 ;Copyright © 2014 Cancer Research UK 2014 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2014.69 ;PMID: 24548861 ;CODEN: BJCAAI

Full text available

Results 1 - 20 of 781,987  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1969  (143)
  2. 1969 To 1981  (122)
  3. 1982 To 1994  (71,980)
  4. 1995 To 2008  (249,860)
  5. After 2008  (459,888)
  6. More options open sub menu

Subject 

  1. Humans  (781,972)
  2. Male  (781,767)
  3. Aged  (755,048)
  4. Female  (722,705)
  5. Middle Aged  (652,062)
  6. Science & Technology  (636,527)
  7. Life Sciences & Biomedicine  (621,725)
  8. Adult  (485,415)
  9. Biological And Medical Sciences  (205,282)
  10. Medical Sciences  (194,866)
  11. Adolescent  (170,670)
  12. Retrospective Studies  (162,749)
  13. Young Adult  (132,250)
  14. Treatment Outcome  (120,721)
  15. Risk Factors  (111,560)
  16. Surgery  (105,516)
  17. Prospective Studies  (85,089)
  18. Follow-Up Studies  (79,913)
  19. Oncology  (73,550)
  20. More options open sub menu

Language 

  1. English  (714,215)
  2. Japanese  (122,990)
  3. German  (13,021)
  4. Spanish  (11,721)
  5. French  (10,597)
  6. Chinese  (10,190)
  7. Portuguese  (6,560)
  8. Russian  (4,631)
  9. Italian  (4,412)
  10. Polish  (2,227)
  11. Czech  (1,128)
  12. Dutch  (1,094)
  13. Hungarian  (498)
  14. Norwegian  (412)
  15. Turkish  (408)
  16. Romanian  (403)
  17. Korean  (378)
  18. Croatian  (301)
  19. Ukrainian  (267)
  20. Danish  (252)
  21. More options open sub menu

Searching Remote Databases, Please Wait